Lifelong course of positive and negative symptoms in chronically institutionalized patients with schizophrenia

Psychopathology

Volumn 40, Issue 2, 2007, Pages 83-92

  Mancevski, Branislav ^a,b   Keilp, John ^a,b   Kurzon, Matthew ^a   Berman, Robert M ^b   Ortakov, Vladimir ^c   Harkavy Friedman, Jill ^a,b   Rosoklija, Gorazd ^a,b,c   Dwork, Andrew J ^a,b,d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^d NONE   (United States)

Author keywords

Antipsychotic agents; Longitudinal course; Negative symptoms; Positive symptoms; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; AUTOPSY; CHRONIC DISEASE; COGNITIVE DEFECT; DEATH; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; INSTITUTIONALIZATION; LONGITUDINAL STUDY; MALE; MEDICAL RECORD REVIEW; NEGATIVE SYNDROME; ONSET AGE; POSITIVE SYNDROME; RATING SCALE; SCHIZOPHRENIA; SEX DIFFERENCE;

ACTIVITIES OF DAILY LIVING; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; CUSTODIAL CARE; DELUSIONS; DEPRESSION; FEMALE; HALLUCINATIONS; HUMANS; INSTITUTIONALIZATION; LONGITUDINAL STUDIES; MALE; MEDICAL RECORDS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS;

EID: 33846862895     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098488     Document Type: Article

References (53)

1. McGlashan TH: A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 1988;14:515-542.
2. Engelhardt DM, Rosen B, Feldman J, Engelhardt JA, Cohen P: A 15-year follow-up of 646 schizophrenic outpatients. Schizophr Bull 1982;8:493-503.
3. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A: The Vermont longitudinal study of persons with severe mental illness. 1. Methodology, study sample, and overall status 32 years later. Am J Psychiatry 1987;144:718-726.
4. Gardos G, Cole JO, LaBrie RA: A 12-year follow-up study of chronic schizophrenics. Hosp Community Psychiatry 1982;33:983-984.
5. McGlashan TH: The Chestnut Lodge followup study. 1. Follow-up methodology and study sample. Arch Gen Psychiatry 1984;41:573-585.
6. McGlashan TH: The Chestnut Lodge follow-up study. 2. Long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiatry 1984;41:586-601.
7. Andia AM, Zisook S, Heaton RK, Hesselink J, Jernigan T, Kuck J, Morganville J, Braff DL: Gender differences in schizophrenia. J Nerv Ment Dis 1995;183:522-528.
8. Gur RE, Petty RG, Turetsky BI, Gur RC: Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophr Res 1996;21:1-12.
9. Johnstone EC, Owens DG, Frith CD, Crow TJ: The relative stability of positive and negative features in chronic schizophrenia. Br J Psychiatry 1987;150:60-64.
10. Pogue-Geile MF, Harrow M: Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr Bull 1985;11:427-439.
11. Mueser KT, Douglas MS, Bellack AS, Morrison RL: Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bull 1991;17:565-582.
12. Putnam KM, Harvey PD, Parrella M, White L, Kincaid M, Powchik P, Davidson M: Symptom stability in geriatric chronic schizophrenic inpatients: a one-year follow-up study. Biol Psychiatry 1996;39:92-99.
13. Ortakov V, Mancevski B, Keilp J, Oppenheim S, Dwork AJ: Application of cognitive scales to medical records of schizophrenia inpatients. Schizophr Res 1999;35:131-140.
14. Seeman MV: Gender differences in schizophrenia. Can J Psychiatry 1982;27:107-112.
15. Loranger AW: Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984;41:157-161.
16. Goldstein JM: Gender differences in the course of schizophrenia. Am J Psychiatry 1988;145:684-689.
17. Goldstein JM, Santangelo SL, Simpson JC, Tsuang MT: The role of gender in identifying subtypes of schizophrenia: a latent class analytic approach. Schizophr Bull 1990;16:263-275.
18. Marneros A: Frequency of occurrence of Schneider's first rank symptoms in schizophrenia. Eur Arch Psychiatry Neurol Sci 1984;234:78-82.
19. McGlashan TH, Bardenstein KK: Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull 1990;16:319-329.
20. Dwork AJ, Susser ES, Keilp J, Waniek C, Liu D, Kaufman M, Zemishlany Z, Prohovnik I: Senile degeneration and cognitive impairment in chronic schizophrenia. Am J Psychiatry 1998;155:1536-1543.
21. Keilp JG, Waniek C, Goldman RG, Zemishlany Z, Alexander GE, Gibbon M, Wu A, Susser E, Prohovnik I: Reliability of post-mortem chart diagnoses of schizophrenia and dementia. Schizophr Res 1995;17:221-228.
22. Angermeyer MC, Kuhn L, Goldstein JM: Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 1990;16:293-307.
23. Pfohl B, Winokur G: The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics. Br J Psychiatry 1982;141:567-572.
24. Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC: The life course of schizophrenia: age and symptom dimensions. Schizophr Res 1997;23:15-23.
25. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P: A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry 1995;52:352-360.
26. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, Losonczy MF, Keefe RS, Katz S, Frecska E: Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 1995;152:197-207.
27. Jeste DV, Harris MJ, Krull A, Kuck J, Mc Adams LA, Heaton R: Clinical and neuropsychological characteristics of patients with lateonset schizophrenia. Am J Psychiatry 1995;152:722-730.
28. Harris MJ, Jeste DV: Late-onset schizophrenia: an overview. Schizophr Bull 1988;14:39-55.
29. Lindamer LA, Lohr JB, Harris MJ, McAdams LA, Jeste DV: Gender-related clinical differences in older patients with schizophrenia. J Clin Psychiatry 1999;60:61-67.
30. Goldstein JM, Link BG: Gender and the expression of schizophrenia. J Psychiatr Res 1988;22:141-155.
31. Hoff AL, Wieneke M, Faustman WO, Horon R, Sakuma M, Blankfeld H, Espinoza S, De Lisi LE: Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients. Am J Psychiatry 1998;155:1437-1439.
32. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Gur RC: Gender differences in the clinical expression of schizophrenia. Schizophr Res 1992;7:225-231.
33. Cancro R: The introduction of neuroleptics: a psychiatric revolution. Psychiatr Serv 2000;51:333-335.
34. Pfohl B, Winokur G: The micropsychopathology of hebephrenic/catatonic schizophrenia. J Nerv Ment Dis 1983;171:296-300.
35. Ciompi L: The natural history of schizophrenia in the long term. Br J Psychiatry 1980;136:413-420.
36. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC: A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986;148:120-127.
37. DeQuardo JR: Pharmacologic treatment of first-episode schizophrenia: early intervention is key to outcome. J Clin Psychiatry 1998;59(suppl 19):9-17.
38. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR: Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183-1188.
39. Wyatt RJ: Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia. Schizophr Res 1991;5:201-202.
40. Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC: Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001;47:215-222.
41. Wyatt RJ, Henter ID: The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J Psychiatr Res 1998;32:169-177.
42. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J: Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995;152:698-703.
43. Larsen TK, Johannessen JO, Opjordsmoen S: First-episode schizophrenia with long duration of untreated psychosis. Pathways to care. Br J Psychiatry Suppl 1998;33:45-52.
44. Tirupati NS, Rangaswamy T, Raman P: Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust NZ J Psychiatry 2004;38:339-343.
45. Kane JM, Rifkin A, Quitkin F, Nayak D, Ramos-Lorenzi J: Fluphenazine vs. placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatry 1982;39:70-73.
46. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241-247.
47. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR, Hirsch SR: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998;65:446-453.
48. Glantz LA, Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000;57:65-73.
49. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, Hays AP, Dwork AJ: Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000;57:349-356.
50. Eastwood SL: The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol 2004;59:47-72.
51. Feinberg I: Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17:319-334.
52. Hoffman RE, McGlashan TH: Synaptic elimination, neurodevelopment, and the mechanism of hallucinated 'voices' in schizophrenia. Am J Psychiatry 1997;154:1683-1689.
53. McGlashan TH, Hoffman RE: Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57:637-648.